POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		2v3s SERINE/THREONINE-PRO
TEIN KINASE OSR1
(Homo
sapiens)		4 / 8ASP A 459
VAL A 482
PHE A 452
LEU A 436
None
1.01A22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		3j7y MS30
(Homo
sapiens)		4 / 8TYR s 402
ASP s 363
PHE s 176
LEU s 150
None
1.02A22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		3zkm FAB HEAVY CHAIN
(Homo
sapiens)		4 / 8TYR C  93
ASP C  88
PHE C  63
LEU C  48
None
GOL  C1217 ( 4.5A)
GOL  C1217 (-4.0A)
None
0.83A21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		4rwy ANTIBODY 8ANC131
HEAVY CHAIN
(Homo
sapiens)		4 / 8TYR H  90
ASP H  85
PHE H  63
LEU H  48
None
0.80A22.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		4x5t PROTON-GATED ION
CHANNEL,GLRA1
PROTEIN,GLRA1
PROTEIN
(Gloeobacter
violaceus;
Homo
sapiens)		4 / 8TYR A  23
ASN A 152
ASP A 153
ASP A 154
None
0.62A71.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		4xhu PROTEIN TIMELESS
HOMOLOG
(Homo
sapiens)		4 / 8ASP D  36
ASP D  37
VAL D  47
LEU D  31
None
0.95A15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		5czr CADHERIN-RELATED
FAMILY MEMBER 2
(Homo
sapiens)		4 / 8ASP A 152
VAL A 211
PHE A 157
LEU A 167
None
0.88A23.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		5foe GDP-FUCOSE PROTEIN
O-FUCOSYLTRANSFERASE
2,THROMBOSPONDIN-1
(Caenorhabditis
elegans;
Homo
sapiens)		4 / 8ASP A 262
ASP A 259
VAL A 244
LEU A 369
None
1.06A20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		5h1k GEM-ASSOCIATED
PROTEIN 5
(Homo
sapiens)		4 / 8ASP A  95
VAL A  36
PHE A  72
LEU A  27
None
0.75A18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_A_RKEA401_1
(PROTON-GATED ION
CHANNEL)		5jpz SQUAMOUS CELL
CARCINOMA ANTIGEN
RECOGNIZED BY
T-CELLS 3
(Homo
sapiens)		4 / 8TYR A 285
ASP A 261
LEU A 289
LYS A 296
None
1.00A21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		3j7y MS30
(Homo
sapiens)		4 / 8TYR s 402
ASP s 363
PHE s 176
LEU s 150
None
1.09A22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		3keh GLUCOCEREBROSIDASE
(Homo
sapiens)		4 / 8VAL A  17
PHE A   9
LEU A 354
LYS A   7
None
1.09A21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		3p8c NCK-ASSOCIATED
PROTEIN 1
(Homo
sapiens)		4 / 8TYR B 133
ASP B 115
VAL B 107
PHE B 196
None
1.07A14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		3zkm FAB HEAVY CHAIN
(Homo
sapiens)		4 / 8TYR C  93
ASP C  88
PHE C  63
LEU C  48
None
GOL  C1217 ( 4.5A)
GOL  C1217 (-4.0A)
None
0.84A21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		4rwy ANTIBODY 8ANC131
HEAVY CHAIN
(Homo
sapiens)		4 / 8TYR H  90
ASP H  85
PHE H  63
LEU H  48
None
0.83A22.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		4x5t PROTON-GATED ION
CHANNEL,GLRA1
PROTEIN,GLRA1
PROTEIN
(Gloeobacter
violaceus;
Homo
sapiens)		4 / 8TYR A  23
ASN A 152
ASP A 153
ASP A 154
None
0.62A71.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		4xhu PROTEIN TIMELESS
HOMOLOG
(Homo
sapiens)		4 / 8ASP D  36
ASP D  37
VAL D  47
LEU D  31
None
0.91A15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		5czr CADHERIN-RELATED
FAMILY MEMBER 2
(Homo
sapiens)		4 / 8ASP A 152
VAL A 211
PHE A 157
LEU A 167
None
0.88A23.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		5foe GDP-FUCOSE PROTEIN
O-FUCOSYLTRANSFERASE
2,THROMBOSPONDIN-1
(Caenorhabditis
elegans;
Homo
sapiens)		4 / 8ASP A 262
ASP A 259
VAL A 244
LEU A 369
None
1.10A20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		5h1k GEM-ASSOCIATED
PROTEIN 5
(Homo
sapiens)		4 / 8ASP A  95
VAL A  36
PHE A  72
LEU A  27
None
0.81A18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)		5jpz SQUAMOUS CELL
CARCINOMA ANTIGEN
RECOGNIZED BY
T-CELLS 3
(Homo
sapiens)		4 / 8TYR A 285
ASP A 261
LEU A 289
LYS A 296
None
1.02A21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		2v3s SERINE/THREONINE-PRO
TEIN KINASE OSR1
(Homo
sapiens)		4 / 8ASP A 459
VAL A 482
PHE A 452
LEU A 436
None
1.02A22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		3j7y MS30
(Homo
sapiens)		4 / 8TYR s 402
ASP s 363
PHE s 176
LEU s 150
None
1.05A22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		3keh GLUCOCEREBROSIDASE
(Homo
sapiens)		4 / 8VAL A  17
PHE A   9
LEU A 354
LYS A   7
None
1.09A21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		3zkm FAB HEAVY CHAIN
(Homo
sapiens)		4 / 8TYR C  93
ASP C  88
PHE C  63
LEU C  48
None
GOL  C1217 ( 4.5A)
GOL  C1217 (-4.0A)
None
0.82A21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		4rwy ANTIBODY 8ANC131
HEAVY CHAIN
(Homo
sapiens)		4 / 8TYR H  90
ASP H  85
PHE H  63
LEU H  48
None
0.80A22.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		4x5t PROTON-GATED ION
CHANNEL,GLRA1
PROTEIN,GLRA1
PROTEIN
(Gloeobacter
violaceus;
Homo
sapiens)		4 / 8TYR A  23
ASN A 152
ASP A 153
ASP A 154
None
0.62A71.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		4xhu PROTEIN TIMELESS
HOMOLOG
(Homo
sapiens)		4 / 8ASP D  36
ASP D  37
VAL D  47
LEU D  31
None
0.94A15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		5czr CADHERIN-RELATED
FAMILY MEMBER 2
(Homo
sapiens)		4 / 8ASP A 152
VAL A 211
PHE A 157
LEU A 167
None
0.87A23.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		5foe GDP-FUCOSE PROTEIN
O-FUCOSYLTRANSFERASE
2,THROMBOSPONDIN-1
(Caenorhabditis
elegans;
Homo
sapiens)		4 / 8ASP A 262
ASP A 259
VAL A 244
LEU A 369
None
1.06A20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		5h1k GEM-ASSOCIATED
PROTEIN 5
(Homo
sapiens)		4 / 8ASP A  95
VAL A  36
PHE A  72
LEU A  27
None
0.77A18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)		5jpz SQUAMOUS CELL
CARCINOMA ANTIGEN
RECOGNIZED BY
T-CELLS 3
(Homo
sapiens)		4 / 8TYR A 285
ASP A 261
LEU A 289
LYS A 296
None
1.01A21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		2v3s SERINE/THREONINE-PRO
TEIN KINASE OSR1
(Homo
sapiens)		4 / 8ASP A 459
VAL A 482
PHE A 452
LEU A 436
None
1.01A22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		3j7y MS30
(Homo
sapiens)		4 / 8TYR s 402
ASP s 363
PHE s 176
LEU s 150
None
1.04A22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		3zkm FAB HEAVY CHAIN
(Homo
sapiens)		4 / 8TYR C  93
ASP C  88
PHE C  63
LEU C  48
None
GOL  C1217 ( 4.5A)
GOL  C1217 (-4.0A)
None
0.83A21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		4rwy ANTIBODY 8ANC131
HEAVY CHAIN
(Homo
sapiens)		4 / 8TYR H  90
ASP H  85
PHE H  63
LEU H  48
None
0.80A22.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		4x5t PROTON-GATED ION
CHANNEL,GLRA1
PROTEIN,GLRA1
PROTEIN
(Gloeobacter
violaceus;
Homo
sapiens)		4 / 8TYR A  23
ASN A 152
ASP A 153
ASP A 154
None
0.62A71.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		4xhu PROTEIN TIMELESS
HOMOLOG
(Homo
sapiens)		4 / 8ASP D  36
ASP D  37
VAL D  47
LEU D  31
None
0.94A15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		5czr CADHERIN-RELATED
FAMILY MEMBER 2
(Homo
sapiens)		4 / 8ASP A 152
VAL A 211
PHE A 157
LEU A 167
None
0.88A23.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		5foe GDP-FUCOSE PROTEIN
O-FUCOSYLTRANSFERASE
2,THROMBOSPONDIN-1
(Caenorhabditis
elegans;
Homo
sapiens)		4 / 8ASP A 262
ASP A 259
VAL A 244
LEU A 369
None
1.07A20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		5h1k GEM-ASSOCIATED
PROTEIN 5
(Homo
sapiens)		4 / 8ASP A  95
VAL A  36
PHE A  72
LEU A  27
None
0.77A18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)		5jpz SQUAMOUS CELL
CARCINOMA ANTIGEN
RECOGNIZED BY
T-CELLS 3
(Homo
sapiens)		4 / 8TYR A 285
ASP A 261
LEU A 289
LYS A 296
None
1.00A21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		3j7y MS30
(Homo
sapiens)		4 / 8PHE s 176
LEU s 150
TYR s 402
ASP s 363
None
1.08A22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		3keh GLUCOCEREBROSIDASE
(Homo
sapiens)		4 / 8VAL A  17
PHE A   9
LEU A 354
LYS A   7
None
1.09A21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		3p8c NCK-ASSOCIATED
PROTEIN 1
(Homo
sapiens)		4 / 8VAL B 107
PHE B 196
TYR B 133
ASP B 115
None
1.09A14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		3zkm FAB HEAVY CHAIN
(Homo
sapiens)		4 / 8PHE C  63
LEU C  48
TYR C  93
ASP C  88
GOL  C1217 (-4.0A)
None
None
GOL  C1217 ( 4.5A)
0.83A21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		4rwy ANTIBODY 8ANC131
HEAVY CHAIN
(Homo
sapiens)		4 / 8PHE H  63
LEU H  48
TYR H  90
ASP H  85
None
0.81A22.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		4x5t PROTON-GATED ION
CHANNEL,GLRA1
PROTEIN,GLRA1
PROTEIN
(Gloeobacter
violaceus;
Homo
sapiens)		4 / 8TYR A  23
ASN A 152
ASP A 153
ASP A 154
None
0.62A71.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		4xhu PROTEIN TIMELESS
HOMOLOG
(Homo
sapiens)		4 / 8VAL D  47
LEU D  31
ASP D  36
ASP D  37
None
0.93A15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		5czr CADHERIN-RELATED
FAMILY MEMBER 2
(Homo
sapiens)		4 / 8VAL A 211
PHE A 157
LEU A 167
ASP A 152
None
0.88A23.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		5foe GDP-FUCOSE PROTEIN
O-FUCOSYLTRANSFERASE
2,THROMBOSPONDIN-1
(Caenorhabditis
elegans;
Homo
sapiens)		4 / 8VAL A 244
LEU A 369
ASP A 262
ASP A 259
None
1.09A20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		5h1k GEM-ASSOCIATED
PROTEIN 5
(Homo
sapiens)		4 / 8VAL A  36
PHE A  72
LEU A  27
ASP A  95
None
0.79A18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)		5jpz SQUAMOUS CELL
CARCINOMA ANTIGEN
RECOGNIZED BY
T-CELLS 3
(Homo
sapiens)		4 / 8LEU A 289
LYS A 296
TYR A 285
ASP A 261
None
1.00A21.06